National Comprehensive Cancer Network
- Educational Events & Resources
- NCCN Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™
- NCCN Annual Congress: Hematologic Malignancies™
- NCCN Annual Forum: Innovative Diagnostics & Therapeutics in Cancer Care™
- Regional Guidelines in Oncology Symposia
- NCCN Academy for Excellence & Leadership in Oncology™
- NCCN Oncology Research Best Practices Conference™
- Interactive CME
- NCCN Oncology Case Management Program™
- NCCN International Programs
About NCCN
About NCCN
The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
World-renowned experts from NCCN Member Institutions diagnose and treat patients with a broad spectrum of cancers and are recognized for dealing with complex, aggressive, or rare cancers. More than 160,000 new patients receive cancer care at NCCN Member Institutions over the course of any year. NCCN Member Institutions pioneered the concept of the multidisciplinary team approach to patient care and lead the fight against cancer as they integrate programs in patient care, research, and education. Our programs offer access to expert physicians, superior treatment, and quality and safety initiatives that continuously improve the effectiveness and efficiency of cancer care. Thirty-eight Nobel Prize winners have served on the faculties of NCCN Member Institutions.
NCCN News
NCCN News includes all the latest announcements about NCCN programs, educational materials and upcoming events as well as recent press coverage.
NCCN Leadership
NCCN’s Board of Directors is comprised of key leadership from each of the 21 NCCN Member Institutions. Led by Al B. Benson III, MD, from Robert H. Lurie Comprehensive Cancer Center of Northwestern University, this group provides oversight for NCCN activities. NCCN CEO, William T. McGivney, PhD, provides overall direction for the organization.
NCCN Corporate Council
The NCCN Corporate Council is an important resource for the development and expansion of NCCN programs. NCCN gratefully acknowledges the support and commitment of these companies to the improvement of the treatments available to the patients whom we all serve. We also appreciate the recognition of NCCN's necessary autonomy in all decision-making regarding the conclusions, recommendations and outcomes of NCCN programs and resources.
NCCN Employment Opportunities
NCCN is an Equal Opportunity Employer in a significant growth phase. If you would like to become part of our premier organization dedicated to developing programs and products to enhance cancer care, please see our employment opportunities. We offer competitive salaries and excellent benefits.
NCCN Supporter and Exhibitor Opportunities
Organizations who are interested in supporting NCCN programs are encouraged to contact Lyn Fitzgerald, Director, Pharma/Biotech.
Organizations who are interested in exhibiting at NCCN programs are encouraged to contact Jennifer Tredwell, Senior Advertising Manager.
Permission Requests
Please go to our Permission Request Section to submit a request.
NCCN Disclosure of Organizational Relationships
The National Comprehensive Cancer Network (NCCN) is a 501(c)3 not-for-profit alliance of 21 of the world’s leading cancer centers. All NCCN Member Institutions are not-for-profit organizations. NCCN and its Member Institutions are dedicated to improving the quality and effectiveness of care provided to patients with cancer. NCCN develops scientific, evaluative information to inform and improve decisions that can lead to better care. The development of NCCN information is based upon the independent evaluation of available scientific evidence integrated with the expert judgment of leading clinicians.
NCCN Member Institutions
The NCCN Member Institutions are:
- City of Hope Comprehensive Cancer Center, Los Angeles, CA
- Dana-Farber/Brigham and Women’s Cancer Center
Massachusetts General Hospital Cancer Center, Boston, MA - Duke Comprehensive Cancer Center, Durham, NC
- Fox Chase Cancer Center, Philadelphia, PA
- Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
- Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
- Memorial Sloan-Kettering Cancer Center, New York, NY
- H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
- The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH
- Roswell Park Cancer Institute, Buffalo, NY
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO
- St. Jude Children's Research Hospital/University of Tennessee Cancer Institute, Memphis, TN
- Stanford Comprehensive Cancer Center, Stanford, CA
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
- University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
- UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE
- The University of Texas M. D. Anderson Cancer Center, Houston, TX
- Vanderbilt-Ingram Cancer Center, Nashville, TN
NCCN Website Supporters
|
|
|
||
|
|
|
|
|
Email
Print
Mark
